Ferrocene Aromatic Drug Derivative
Ferrocene-based aromatic metallocene used in anti-cancer drug development with iron-carbon sandwich structure. HTS 2931.90.22.00 covers this aromatic organo-inorganic pharmaceutical as metal is linked through carbon atoms.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If copper-based metallocene
Specific organo-inorganic metals have dedicated subheadings within 2931.90.
If cyclopentadienyl alcohol function predominates
Alcohol-function takes precedence over metallocene structure per Chapter notes.
If inorganic ferrocene salt
Inorganic coordination compounds lacking qualifying C-metal bonds classify in Chapter 28.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Demonstrate therapeutic redox properties qualifying as drug via published pharmacology studies
• Use airtight secondary packaging for air-sensitive metallocenes during ocean transport
• Classify under proper HS code for EAR/ITAR if dual-use pharmaceutical technology
Related Products under HTS 2931.90.22.00
Aromatic Arsenic Drug Triphenylarsine Oxide
Triphenylarsine oxide is an aromatic organo-arsenic compound used as an intermediate in pharmaceutical synthesis for anti-cancer drugs. It falls under HTS 2931.90.22.00 as an aromatic organo-inorganic drug containing arsenic directly linked to carbon, meeting Chapter 29 requirements for chemically defined compounds.
4-Dimethylaminophenylarsine Drug Intermediate
This aromatic organo-arsenic compound serves as a key intermediate in synthesizing anti-parasitic drugs. Classified under HTS 2931.90.22.00 due to its aromatic structure with arsenic directly bonded to carbon and designated pharmaceutical application.
Phenylphosphine Gold Drug Auranofin Intermediate
Auranofin intermediate featuring aromatic phosphine coordinated with gold, used in rheumatoid arthritis treatment. Falls under HTS 2931.90.22.00 as an aromatic organo-inorganic drug with phosphorus and metal directly linked to aromatic carbon.
Aromatic Silane Platinum Anti-Cancer Drug
Platinum-based chemotherapy agent with aromatic silane ligands, used in cancer treatment protocols. HTS 2931.90.22.00 classification applies to this aromatic organo-inorganic compound containing silicon and platinum linked to carbon.
Organotin Aromatic Drug Candidate
Aromatic organotin compound under development for anti-microbial pharmaceutical applications. Classified in HTS 2931.90.22.00 as an aromatic organo-inorganic drug with tin directly bonded to aromatic carbon.
Aryl Boronic Acid Platinum Drug Complex
Platinum anti-tumor agent featuring aromatic boronic acid ligands for targeted cancer therapy. Falls under HTS 2931.90.22.00 as aromatic organo-inorganic containing boron and platinum linked to carbon.